Geometry Dash APK Hill Climb Racing APK
39.2 F
New York
Monday, January 17, 2022

Novavax (NASDAQ:NVAX) Gains Further Momentum: Up Nearly 10% Early

Must read

Humbl Inc (OTCMKTS:TSNPD) Bounces Back and Lands On The Radar

Over the course of the past months, Humbl Inc (OTCMKTS:TSNPD) stock has managed to record massive gains and much of that has...

Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Looks to Maintain Critical Momentum

Stocks that make massive gains over a reasonable period of time cannot hope to maintain them forever. At some point, a correction...

Green Thumb Industries Inc (OTCMKTS:GTBIF) Trades Near All-Time High: What Next?

After having been in the dumps for more than a year, the cannabis sector has managed to make a remarkable comeback. Investors...

VIVO Cannabis Inc (OTCMKTS:VVCIF) Stock Turns Volatile: Uptrend in Jeopardy

Anyone watching the market knows the cannabis sector has been booming again. Since the start of the year, the cannabis sector has...

Over the past months, there has been a lot of anticipation about the vaccine specialist biotech company Novavax, Inc. (NASDAQ:NVAX) and its products. Today, the company announced highly positive news with regards to one of its most crucial products. The company announced highly positive results from the Phase 3 trial for its much-anticipated flu vaccine NanoFlu.

Important Development

The positive results generated a lot of optimism about the stock, and the Novavax stock went up by as much as 36% on the back of the news. The stock is likely going to be in sharp focus this morning on the back of this development.

The company revealed that the vaccine NanoFlu managed to hit both the primary as well as secondary endpoints during the Phase 3 study. It is a significant development, and the rally in the stock is understandable. The Chief Executive Officer of the company, Stanley Erck, stated spoke about the possibility of bringing the product as quickly to the market as possible.

He said, “We expect that both Fast Track designation and the accelerated approval pathway from the FDA will help Novavax bring NanoFlu to market as quickly as possible.” He said that influenza is a public health threat, and NanoFlu will help in tackling that.

However, that is not all. Novavax also demonstrated a significant level of effectiveness than Sanofi’s Fluzone Quadrivalent, which is the market leader in this segment. According to reports, NanoFlu performed better than Fluzone Quadrivalent in terms of two key attributes, seroconversion rates (SCR) and geometric mean titers (GMT) for all four strains of flu.

This is another major reason why the market feels so encouraged about the product from Novavax. It is, without a doubt, a critical milestone for the company and one that could help Novavax in bringing their much-anticipated product into the market at last. Investors could do well to keep a close eye on the developments over the coming days.

Latest article

iQSTEL Inc (OTCMKTS:IQST) Stock Makes a Big Move: Jumps 45% In a Week

In the past week, iQSTEL Inc (OTCMKTS: IQST) has emerged as a point of focus among a large number of investors and...

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service